Skip to main content
Clinical Trials/CTRI/2012/02/002398
CTRI/2012/02/002398
Completed
Phase 4

Epidemiological study to evaluate the dietary composition of Indian type-2 diabetic patients compared to non-diabetic population - STARCH

Bayer Pharmaceuticals0 sites800 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Diabetic population and non diabetic populaion
Sponsor
Bayer Pharmaceuticals
Enrollment
800
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Diabetic Population
  • Patients willing to provide signed \& dated informed consent and comply with study
  • Indian diabetic population diagnosed with T2DM for at least 12 months
  • Male and non pregnant female with age18 years or more
  • Non\-Diabetic Population
  • Indian non\-diabetic population who are not following any diet plan or dietary advice
  • Patients willing to provide signed \& dated informed consent and comply with study requirements.
  • Male and non pregnant female with age 18 years or more
  • Non\-diabetic population should be matched in terms of age, sex and centre

Exclusion Criteria

  • Patient unwilling to comply with the study procedures
  • Pregnant \& lactating women
  • History of cardiovascular event within the previous six months
  • Patients with specific co morbidities, which may impact the patients diet, e.g malignant diseases, advanced dementia, Parkinsonâ??s disease and others
  • Suffering from chronic diseases including but not limited to chronic renal failure, chronic liver disease that might interfere with participation in the study as per physician discretion.
  • Patients on weight management plan e.g. low carbohydrate diet which includes dietary modifications or dietary alterations

Outcomes

Primary Outcomes

Not specified

Similar Trials